Clinical trial
Systematic Early Use of Neuromuscular Blocking Agents in ARDS Patients
NCT00299650 · Assistance Publique Hopitaux De Marseille, Other · Completed
Key facts
| NCT number | NCT00299650 |
|---|---|
| Title | Systematic Early Use of Neuromuscular Blocking Agents in ARDS Patients |
| Official title | Systematic Early Use of Neuromuscular Blocking Agents in ARDS Patients |
| Lead sponsor | Assistance Publique Hopitaux De Marseille, Other |
| Collaborators | GlaxoSmithKline Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | ARDS |
| Intervention type | Drug |
| Interventions | cisatracurium, Placebo, Cisatracurium besilate |
| Enrollment | 340 |
| Start date | Mar 1, 2006 |
| Primary completion | Oct 1, 2008 |
| Completion | Oct 1, 2008 |
| First posted | Mar 7, 2006 |
| Last update posted | Oct 10, 2008 |
| Countries | France |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: